Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy

Total article views   Abstract views HTML views PDF downloads Totals
701 Dovepress* 422 279+ 100 701
Totals 422 279 100 701
*Since 10 February 2021
+Since July 2016

View citations on Google Scholar